410 related articles for article (PubMed ID: 25634387)
21. Nonalcoholic fatty liver disease as a potential risk factor of cardiovascular disease.
Luo J; Xu L; Li J; Zhao S
Eur J Gastroenterol Hepatol; 2015 Mar; 27(3):193-9. PubMed ID: 25563143
[TBL] [Abstract][Full Text] [Related]
22. Association Between Quantity of Liver Fat and Cardiovascular Risk in Patients With Nonalcoholic Fatty Liver Disease Independent of Nonalcoholic Steatohepatitis.
Arulanandan A; Ang B; Bettencourt R; Hooker J; Behling C; Lin GY; Valasek MA; Ix JH; Schnabl B; Sirlin CB; Loomba R
Clin Gastroenterol Hepatol; 2015 Aug; 13(8):1513-20.e1. PubMed ID: 25661453
[TBL] [Abstract][Full Text] [Related]
23. Relationship between serum uric acid levels and hepatic steatosis in non-obese postmenopausal women.
Liu PJ; Ma F; Lou HP; Zhu YN; Chen Y
Climacteric; 2014 Dec; 17(6):692-9. PubMed ID: 24884478
[TBL] [Abstract][Full Text] [Related]
24. Relation of physical activity to prevalence of nonalcoholic Fatty liver disease independent of cardiometabolic risk.
Oni ET; Kalathiya R; Aneni EC; Martin SS; Blaha MJ; Feldman T; Agatston AS; Blumenthal RS; Conceiçao RD; Carvalho JA; Santos RD; Nasir K
Am J Cardiol; 2015 Jan; 115(1):34-9. PubMed ID: 25456868
[TBL] [Abstract][Full Text] [Related]
25. The relationship of circulating fetuin-a with liver histology and biomarkers of systemic inflammation in nondiabetic subjects with nonalcoholic fatty liver disease.
Celebi G; Genc H; Gurel H; Sertoglu E; Kara M; Tapan S; Acikel C; Karslioglu Y; Ercin CN; Dogru T
Saudi J Gastroenterol; 2015; 21(3):139-45. PubMed ID: 26021772
[TBL] [Abstract][Full Text] [Related]
26. Moderate to severe, but not mild, nonalcoholic fatty liver disease associated with increased risk of gallstone disease.
Lee YC; Wu JS; Yang YC; Chang CS; Lu FH; Chang CJ
Scand J Gastroenterol; 2014 Aug; 49(8):1001-6. PubMed ID: 24989169
[TBL] [Abstract][Full Text] [Related]
27. The effect of a low fructose and low glycemic index/load (FRAGILE) dietary intervention on indices of liver function, cardiometabolic risk factors, and body composition in children and adolescents with nonalcoholic fatty liver disease (NAFLD).
Mager DR; Iñiguez IR; Gilmour S; Yap J
JPEN J Parenter Enteral Nutr; 2015 Jan; 39(1):73-84. PubMed ID: 23976771
[TBL] [Abstract][Full Text] [Related]
28. Nonalcoholic fatty liver disease is independently associated with an increased incidence of cardiovascular disease in adult patients with type 1 diabetes.
Mantovani A; Mingolla L; Rigolon R; Pichiri I; Cavalieri V; Zoppini G; Lippi G; Bonora E; Targher G
Int J Cardiol; 2016 Dec; 225():387-391. PubMed ID: 27768965
[TBL] [Abstract][Full Text] [Related]
29. Reactive hyperemia index (RHI) and cognitive performance indexes are associated with histologic markers of liver disease in subjects with non-alcoholic fatty liver disease (NAFLD): a case control study.
Tuttolomondo A; Petta S; Casuccio A; Maida C; Corte VD; Daidone M; Di Raimondo D; Pecoraro R; Fonte R; Cirrincione A; Zafonte R; Cabibi D; Cammà C; Di Marco V; Licata A; Magliozzo F; Marchesini G; Merlino G; Craxì A; Pinto A
Cardiovasc Diabetol; 2018 Feb; 17(1):28. PubMed ID: 29452601
[TBL] [Abstract][Full Text] [Related]
30. Hepatic steatosis and nonalcoholic fatty liver disease are common and associated with cardiometabolic risk in a primary prevention cohort of people with HIV.
Lake JE; Taron J; Ribaudo HJ; Leon-Cruz J; Utay NS; Swaminathan S; Fitch KV; Kileel EM; Paradis K; Fulda ES; Ho KS; Luetkemeyer AF; Johnston CD; Zanni MV; Douglas PS; Grinspoon SK; Lu MT; Fichtenbaum CJ;
AIDS; 2023 Nov; 37(14):2149-2159. PubMed ID: 37503623
[TBL] [Abstract][Full Text] [Related]
31. The association between increased alanine aminotransferase activity and metabolic factors in nonalcoholic fatty liver disease.
Oh SY; Cho YK; Kang MS; Yoo TW; Park JH; Kim HJ; Park DI; Sohn CI; Jeon WK; Kim BI; Son BH; Shin JH
Metabolism; 2006 Dec; 55(12):1604-9. PubMed ID: 17142131
[TBL] [Abstract][Full Text] [Related]
32. Relationship between non-alcoholic fatty liver disease and MIA syndrome.
Mikolasevic I; Stimac D; Racki S; Zaputovic L; Devcic B; Jelic I; Lukenda V; Radic M; Orlic L
Hemodial Int; 2015 Jul; 19(3):472-81. PubMed ID: 25688578
[TBL] [Abstract][Full Text] [Related]
33. Evaluation of clinical and inflammatory markers of nonalcoholic fatty liver disease in postmenopausal women with metabolic syndrome.
Rodrigues MH; Bruno AS; Nahas-Neto J; Sandrim VC; Muniz LG; Nahas EA
Metab Syndr Relat Disord; 2014 Aug; 12(6):330-8. PubMed ID: 25051240
[TBL] [Abstract][Full Text] [Related]
34. Prevalence of non-alcoholic fatty liver disease and its correlation with coronary risk factors in patients with type 2 diabetes.
Agarwal AK; Jain V; Singla S; Baruah BP; Arya V; Yadav R; Singh VP
J Assoc Physicians India; 2011 Jun; 59():351-4. PubMed ID: 21751587
[TBL] [Abstract][Full Text] [Related]
35. Nonalcoholic fatty liver disease and cardiovascular disease.
Hyogo H; Chayama K; Yamagishi S
Curr Pharm Des; 2014; 20(14):2403-11. PubMed ID: 23844815
[TBL] [Abstract][Full Text] [Related]
36. Patients with psoriasis are at a higher risk of developing nonalcoholic fatty liver disease.
Abedini R; Salehi M; Lajevardi V; Beygi S
Clin Exp Dermatol; 2015 Oct; 40(7):722-7. PubMed ID: 25958919
[TBL] [Abstract][Full Text] [Related]
37. A vegetarian diet does not protect against nonalcoholic fatty liver disease (NAFLD): A cross-sectional study between Buddhist priests and the general population.
Choi SH; Oh DJ; Kwon KH; Lee JK; Koh MS; Lee JH; Kang HW
Turk J Gastroenterol; 2015 Jul; 26(4):336-43. PubMed ID: 26039004
[TBL] [Abstract][Full Text] [Related]
38. Ambulatory arterial stiffness indices and non-alcoholic fatty liver disease in essential hypertension.
Catena C; Bernardi S; Sabato N; Grillo A; Ermani M; Sechi LA; Fabris B; Carretta R; Fallo F
Nutr Metab Cardiovasc Dis; 2013 Apr; 23(4):389-93. PubMed ID: 22796347
[TBL] [Abstract][Full Text] [Related]
39. Increased Plasma Levels of Asymmetric Dimethylarginine in Nonalcoholic Fatty Liver Disease: Relation With Insulin Resistance, Inflammation, and Liver Histology.
Boga S; Alkim H; Koksal AR; Bayram M; Ozguven MB; Ergun M; Neijmann ST; Ozgon G; Alkim C
J Investig Med; 2015 Oct; 63(7):871-7. PubMed ID: 26244718
[TBL] [Abstract][Full Text] [Related]
40. Non-alcoholic fatty liver disease (NAFLD) and 10-year risk of cardiovascular diseases.
Motamed N; Rabiee B; Poustchi H; Dehestani B; Hemasi GR; Khonsari MR; Maadi M; Saeedian FS; Zamani F
Clin Res Hepatol Gastroenterol; 2017 Feb; 41(1):31-38. PubMed ID: 27597641
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
